Sept 2025 saw 11 IPO listings, with strong debuts as 10 opened in the green, averaging 9.57% gains. However, post-listing performance faltered, with only 5 trading above issue price and 6 slipping below.Read More
20 IPOs open soon on Dalal Street; Fabtech leads with 18% GMP, others show 6–10% or flat. Early grey market activity hints at listing gains and investor interest.Read More
Foreign portfolio investors (FPIs) offloaded Rs 16,422 crore worth of Indian equities last week, driven by concerns over valuations and new policy measures of US government but the sentiment is set to reverse, analysts said on Sunday.Read More
HSBC reiterates “Buy” on Eternal, raising its target to Rs 390, citing strong scale, margin leadership, and robust cash reserves. Swiggy remains on “Hold” due to slower margin growth, high cash burn, and execution risks, despite rising average order values. Eternal outperforms in quick commerce and food delivery segments.Read More
Indian markets ended the week down 2.7%, dragged by IT and pharma amid U.S. tariff and visa fee worries. Key drivers ahead include RBI policy outcome, U.S. market cues, IPO rush, rupee weakness, and crude price trends. Analysts suggest caution with focus on fundamentally strong stocks.Read More
Pharma and IT stocks faced heavy pressure after Trump’s 100% tariff and H-1B visa fee hike, dragging Nifty lower. Laurus Labs showed a topping pattern while Wockhardt stayed in consolidation. Nifty IT broke support, hinting further downside. Analysts suggest cautious trading, with Tata Motors and VTL offering potential bullish setups.Read More
Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Donec sed odio dui. Etiam porta sem malesuada.
